Article
European Commission authorises GSK's HIV prevention drug
Rating:
0.0
Views:
49
Likes:
1
Library:
1
The European Commission has authorised GSK's HIV-focused unit ViiV Healthcare's cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value